According to Axon Enterprise 's latest financial reports the company's total assets are $3.61 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $3.43 B | 20.51% |
2022-12-31 | $2.85 B | 68.93% |
2021-12-31 | $1.68 B | 22.24% |
2020-12-31 | $1.38 B | 63.31% |
2019-12-31 | $0.84 B | 17.52% |
2018-12-31 | $0.71 B | 112.81% |
2017-12-31 | $0.33 B | 21.55% |
2016-12-31 | $0.27 B | 21% |
2015-12-31 | $0.22 B | 24.01% |
2014-12-31 | $0.18 B | 24.93% |
2013-12-31 | $0.14 B | 27.66% |
2012-12-31 | $0.11 B | 10.74% |
2011-12-31 | $0.10 B | -22.93% |
2010-12-31 | $0.13 B | -1.62% |
2009-12-31 | $0.13 B | 6.47% |
2008-12-31 | $0.13 B | -5.62% |
2007-12-31 | $0.13 B | 14.96% |
2006-12-31 | $0.11 B | 6.77% |
2005-12-31 | $0.11 B | 2.55% |
2004-12-31 | $0.10 B | 248.08% |
2003-12-31 | $31.44 M | 297.82% |
2002-12-31 | $7.9 M | -1.87% |
2001-12-31 | $8.05 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
XBiotech XBIT | $0.22 B | -93.70% | ๐บ๐ธ USA |
Sangamo Therapeutics
SGMO | $0.12 B | -96.43% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | N/A | N/A | ๐บ๐ธ USA |
Exelixis EXEL | $2.80 B | -22.47% | ๐บ๐ธ USA |